Shandong Weigao Medical Polymer Company (1066.HK)

Overall impact
C (55)

Commentary

Shandong Weigao Group Medical Polymer is an average overall performer. With a 'C' rating of 54.7 for overall impact (51st percentile compared to all companies), Shandong Weigao Group Medical Polymer ranks 78th out of 103 industry peers, behind Waters, MyMD Pharmaceuticals, Alphatec and 74 others, and ahead of Nanosonics, Penumbra, AtriCure and 22 others. On top material causes for Shandong Weigao Group Medical Polymer's industry (Healthcare Equipment), Shandong Weigao Group Medical Polymer performs poorly in Equal Pay and Opportunity (27.4 score) and Child and Maternal Health (32.1). Shandong Weigao Group Medical Polymer did not receive an 'A' rating on any cause.
Impact
Cause 1066.HK
Peer rank
Overall impact

Log in to view this information

Impact trend

Change in rating for overall impact

Log in to view this information

Company

Shandong Weigao Medical Polymer Company

Employees
13,307
Sector
Health Care
Industry
Health Care Equipment & Supplies
Sub-industry
Health Care Supplies
SASB industry
Medical Equipment & Supplies
Headquarters
China
Share classes
1066.HK
SHWGY
Description
Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, wholesale, and sale of medical devices in the People's Republic of China and internationally. It operates through Medical Device Products, Orthopedic Products, Pharma Packaging Products, Interventional Products, Blood Management Products, and Others segments. The company's medical device products include safe infusion, clinical nursing, perioperative, endocrine, urinary, rehabilitation system, and extracorporeal circulation solutions; and orthopedic products comprise spine, joint, trauma, sports medicine, bone repair material, and spinal endoscope products, as well as orthopedic devices, PRP treatment consumables, and negative pressure drainage consumables. Its pharma packaging products consist of prefilled drug delivery systems, pharmaceutical packaging consumables, automatic drug delivery systems, and pre-filled syringes; interventional products include offers tumor, vascular, and nursing interventions; and blood management products comprise whole blood collection consumables and blood transfusion equipment. The company also provides finance leasing and factoring services; medical PVC granules, plastic packing bags, and carton boxes; medical polymer materials and products; injection puncture instruments; computer technical services; consulting services; and X-ray based irradiation machines. In addition, it sells electronic products. The company was founded in 1988 and is based in Weihai, the People's Republic of China.
Material causes
Ethos considers the following causes material for Shandong Weigao Medical Polymer Company, based on its industry sub-industry Health Care Supplies. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.